| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/07/2004 | US6787354 Diagnosing and detecting cancer in mammals; obtain cells, isolate nucleotide sequences, detect hepsin nucleotide sequences, the presence of hepsin indicates hyperplasia |
| 09/07/2004 | US6787349 Biochip reader and labeling reagent |
| 09/07/2004 | US6787346 Kinase capable of site-specific phosphorylation of IκBα |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/07/2004 | US6787331 Process for examining membrane enclosed biocompartments |
| 09/07/2004 | US6787330 Method and kit for identifying or characterizing polypeptides |
| 09/07/2004 | US6787326 For destruction in normoxic but not hypoxic cells; promotes angiogenesis and/or cellular survival; fusion proteins |
| 09/07/2004 | US6787325 Biotinylation; luciferases; immunoassays |
| 09/07/2004 | US6787324 Method and apparatus for detecting conception in animals |
| 09/07/2004 | US6787323 Monitoring vascular endothelial growth factor activity in a sample; obtain sample, incubate with preferential genetically engineered cells, detecting expression of the reporter element, expression indicates growth factor activity |
| 09/07/2004 | US6787321 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 09/07/2004 | US6787319 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 09/07/2004 | US6787318 Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology |
| 09/07/2004 | US6787317 Method of identifying missing domains in receptors |
| 09/07/2004 | US6787315 Methods for identifying ligand binding sites in a biomolecule |
| 09/07/2004 | US6787313 Dry deposit nondestructive particles on preferential surface; for use in the generation biochip microarrays |
| 09/07/2004 | US6787312 Immobilizing biopolymers on a surface of a substrate; obtain substrate, incubate with biopolymer, expose to reducing agent, join biopolymer to substrate |
| 09/07/2004 | US6787309 Nucleotide sequences coding cardiovascular protein for use in the diagnosis and treatment chromosomal disorder |
| 09/07/2004 | US6787306 Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations |
| 09/07/2004 | US6787302 Detecting viable cells in sample; obtain cells, incubate with fluorescent dyes, detect fluorescence, compare to control |
| 09/07/2004 | US6787154 Artificial antigen presenting cells |
| 09/07/2004 | US6787125 Dispensing nematode worms into multi-well plate containing carboxymethyl cellulose; contacting with chemical; detecting a signal indicating changes; drug screening; high throughput assay |
| 09/07/2004 | US6787109 In particular for the analysis of blood and urine; increased measurement accuracy by an improved temperature compensation. |
| 09/07/2004 | US6787106 Analysis device |
| 09/07/2004 | US6787015 Employing microfluidic device comprising microchannel having neutral nonbornene polymer surface and electrodes for creating electrical field, introducing sample into aqueous dispersion of sieving polymer whereby ions migrate and separate |
| 09/07/2004 | US6787013 Biosensor |
| 09/07/2004 | US6786096 System and technique for detecting the presence of foreign material |
| 09/07/2004 | US6786083 Apparatus and method for assessment of mattresses |
| 09/07/2004 | US6786080 Method for assessing the deterioration of motor oil |
| 09/07/2004 | US6786076 Thin film gas sensor |
| 09/07/2004 | CA2421321A1 Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis |
| 09/07/2004 | CA2248651C Method of identifying mhc-class i restriced antigens endogenously processed by a cellular secretory pathway |
| 09/07/2004 | CA2087006C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 09/02/2004 | WO2004075021A2 Molecular modeling methods |
| 09/02/2004 | WO2004075010A2 Statistically identifying an increased risk for disease |
| 09/02/2004 | WO2004074990A2 Method for determining sequence alignment significance |
| 09/02/2004 | WO2004074976A2 Reording medium, playback device, recording method, playback method, and computer program |
| 09/02/2004 | WO2004074846A1 Blood analysis device and blood analysis method |
| 09/02/2004 | WO2004074844A1 Screening assays for cannabinoid-ligand-type modulators of gpr55 |
| 09/02/2004 | WO2004074843A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep1 (prostaglandin e2 ep1) |
| 09/02/2004 | WO2004074842A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 (prostaglandin e2 ep3) |
| 09/02/2004 | WO2004074841A2 Kor3l-like-proteins and methods of modulating kor3l-mediated activity |
| 09/02/2004 | WO2004074840A1 Method for the quantitative measurement of ligands in the sample of dissolved binding proteins |
| 09/02/2004 | WO2004074839A1 Detection of pathological prionic protein in the olfactory epithelium of subjects affected by sporadic creutzfeldt-jakob disease |
| 09/02/2004 | WO2004074838A1 Quantification of botulinum toxin |
| 09/02/2004 | WO2004074837A1 Method for measuring the level of anti-beta-amyloid antibody in body fluids and diagnostic kit for alzheimer’s disease using same |
| 09/02/2004 | WO2004074836A2 Methods for investigating the specificity of compounds that interact with receptors |
| 09/02/2004 | WO2004074835A1 Microarray devices having controllable reaction volume |
| 09/02/2004 | WO2004074834A1 Molecularly-imprinted chemical detection device and method |
| 09/02/2004 | WO2004074833A1 Method of measuring oxidized ldl-crp complex and measrurement kit |
| 09/02/2004 | WO2004074832A1 Method of evaluating performance of activated gas of inactivating antigenic substance and apparatus for producing treated antigenic substance to be used as evaluation sample in the evaluation method |
| 09/02/2004 | WO2004074831A1 Treatment of hypertension |
| 09/02/2004 | WO2004074830A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 iii (prostaglandin e2 ep3 iii) |
| 09/02/2004 | WO2004074827A1 Measuring instrument for biosensor and measuring method using same |
| 09/02/2004 | WO2004074813A2 Test cartridge, system for sensing fluid, and methods |
| 09/02/2004 | WO2004074812A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | WO2004074810A2 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 09/02/2004 | WO2004074781A2 Method and apparatus for measuring dry density and water content of soil |
| 09/02/2004 | WO2004074762A2 System for characterizing bulk mechanical properties of aerated materials |
| 09/02/2004 | WO2004074515A1 METHOD OF EVALUATING BEEF TASTE, TEXTURE AND SO ON BASED ON STEAROYL-CoA DESATURASE GENOTYPE |
| 09/02/2004 | WO2004074514A2 Method of diagnosis of type 2 diabetes and early onset thereof |
| 09/02/2004 | WO2004074513A1 Methods for the prediction of suicidality during treatment |
| 09/02/2004 | WO2004074511A1 Diagnosis and treatment of baff-mediated autoimmune diseases and cancer |
| 09/02/2004 | WO2004074510A1 Methods of diagnosis and prognosis of pancreatic cancer |
| 09/02/2004 | WO2004074508A2 Method of visualization and quantification of biopolymer molecules immobilized on solid support |
| 09/02/2004 | WO2004074506A2 Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers |
| 09/02/2004 | WO2004074505A2 Method for determining functional sites in a protein |
| 09/02/2004 | WO2004074504A2 Fluorescent silica-based nanoparticles |
| 09/02/2004 | WO2004074484A1 Method of screening apoptosis-controlling agent |
| 09/02/2004 | WO2004074482A1 Diabetes and obesity diagnosis method |
| 09/02/2004 | WO2004074479A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | WO2004074478A1 Method of estimating antitumor effect of histone deacetylase inhibitor |
| 09/02/2004 | WO2004074477A1 Method of measuring homocysteine |
| 09/02/2004 | WO2004074475A1 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same |
| 09/02/2004 | WO2004074473A1 Mutant receptor and process for producing the same, method of separately evalauting ligands with the use of mutant receptor and normal receptor, screening method and kit therefor. |
| 09/02/2004 | WO2004074452A2 Multiplex mapping of protein interactions |
| 09/02/2004 | WO2004074446A2 Parkin interacting polypeptides and methods of use |
| 09/02/2004 | WO2004074445A2 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/02/2004 | WO2004074325A2 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 09/02/2004 | WO2004074321A2 Therapeutic gpcr targets in cancer |
| 09/02/2004 | WO2004074320A2 Therapeutic targets in cancer |
| 09/02/2004 | WO2004074317A1 Peptide derived from a vca-p18 capside antigen of the epstein-barr virus and the use thereof |
| 09/02/2004 | WO2004074310A2 Mycobacterial diagnostics |
| 09/02/2004 | WO2004074276A1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 09/02/2004 | WO2004074246A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | WO2004073990A1 Sheet material information-detecting apparatus |
| 09/02/2004 | WO2004073864A2 Devices for component removal during blood collection, and uses thereof |
| 09/02/2004 | WO2004073739A1 A method of diagnosis and treatment |
| 09/02/2004 | WO2004073724A1 Endogenous pharmaceutical composition produced on the basis of an intentional activation of humoral mediators of the nerve endings of cerebral cortex |
| 09/02/2004 | WO2004073657A2 Methods of diagnosis of cancer and other diseases, composition and methods of screening for modulators of cancer and other diseases |
| 09/02/2004 | WO2004073653A2 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 09/02/2004 | WO2004073651A2 Identifying inhibitors of intracellular protein fibrillization |
| 09/02/2004 | WO2004073645A2 Inhibition of olfatory neurosensory function of treat eating disorders and obesity |
| 09/02/2004 | WO2004073591A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep2 (prostaglandin e2 ep2) |
| 09/02/2004 | WO2004073590A2 Diagnostics and therapeutics for deseases associated with g-protein coupled receptor prostaglandin f2-alpha (prostaglandin f2-alpha) |
| 09/02/2004 | WO2004073589A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep4 (prostaglandin e2 ep4) |
| 09/02/2004 | WO2004073588A2 Diagnostics and therapeutics for diseases associated with g protein coupled receptor r35 (r35) |
| 09/02/2004 | WO2004073587A2 Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 1 (pthr1) |
| 09/02/2004 | WO2004073586A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 09/02/2004 | WO2004073499A2 Diagnosis of primary open angle glaucoma |